Connection

Chih-Cheng Lai to Janus Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Chih-Cheng Lai has written about Janus Kinase Inhibitors.
Chih-Cheng Lai
Connection Strength
0.595
Janus Kinase Inhibitors
  1. Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials. Int Immunopharmacol. 2021 Oct; 99:108027.
    View in: PubMed
    Score: 0.595
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.